Czech medical startup Kardi Ai has raised 130 million crowns in a Series A round, the largest round to date for a Czech medical technology startup. With the round closed, the company is valued at 600 million crowns, almost 1,300 percent more than when it was founded in 2022.
The round drew Seed Startery of Česká spořitelna (Czech Savings Bank) and Slovenská sporiteľňa (Slovak Savings Bank), along with the investors BrightCap, the German venture fund Callisto Health, Purple Ventures and Garage Angels.
Kardi Ai specializes in long-term heart rhythm monitoring and the detection of possible problems. The startup wants to use the new funds to expand in Europe and Asia: Germany in Europe and the Indian market in Asia. The company also plans to invest in predictive models that assess the risk of arrhythmias from measurement data.
According to Kardi Ai co-founder and CEO Vlastimil Hrabal, the company is gradually moving from detecting heart rhythm disorders to technology that can warn of an elevated risk before an arrhythmia appears.
More than six thousand people use Kardi Ai's technology, and in Czechia the startup works with more than seventy hospitals. The company also operates in Poland, Romania, Bulgaria and Slovakia.
By the Around Prague newsroom